These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 17190848

  • 1. Botulinum toxin A in the treatment of sialorrhea.
    Benson J, Daugherty KK.
    Ann Pharmacother; 2007 Jan; 41(1):79-85. PubMed ID: 17190848
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type A treatment for Parkinsonian patients with moderate to severe sialorrhea.
    Su CS, Lan MY, Liu JS, Chang CC, Lai SL, Wu HS, Chen SS, Chang YY.
    Acta Neurol Taiwan; 2006 Sep; 15(3):170-6. PubMed ID: 16995596
    [Abstract] [Full Text] [Related]

  • 3. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
    Mancini F, Zangaglia R, Cristina S, Sommaruga MG, Martignoni E, Nappi G, Pacchetti C.
    Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
    [Abstract] [Full Text] [Related]

  • 4. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
    Fuster Torres MA, Berini Aytés L, Gay Escoda C.
    Med Oral Patol Oral Cir Bucal; 2007 Nov 01; 12(7):E511-7. PubMed ID: 17978775
    [Abstract] [Full Text] [Related]

  • 5. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep 01; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 6. Does botulinum toxin decrease frequency and severity of sialorrhea in Parkinson's disease?
    Nóbrega AC, Rodrigues B, Torres AC, Enzo A, Melo A.
    J Neurol Sci; 2007 Feb 15; 253(1-2):85-7. PubMed ID: 17229441
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A for drooling in Parkinson's disease: a double-blind, randomized, placebo-controlled study.
    Lagalla G, Millevolte M, Capecci M, Provinciali L, Ceravolo MG.
    Mov Disord; 2006 May 15; 21(5):704-7. PubMed ID: 16440332
    [Abstract] [Full Text] [Related]

  • 8. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial.
    Alrefai AH, Aburahma SK, Khader YS.
    Clin Neurol Neurosurg; 2009 Jan 15; 111(1):79-82. PubMed ID: 18977585
    [Abstract] [Full Text] [Related]

  • 9. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
    Banerjee KJ, Glasson C, O'Flaherty SJ.
    Dev Med Child Neurol; 2006 Nov 15; 48(11):883-7. PubMed ID: 17044954
    [Abstract] [Full Text] [Related]

  • 10. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawi R.
    Laryngoscope; 2004 Oct 15; 114(10):1856-60. PubMed ID: 15454785
    [Abstract] [Full Text] [Related]

  • 11. Relevance of intraglandular injections of Botulinum toxin for the treatment of sialorrhea in children with cerebral palsy: a review.
    Porte M, Chaléat-Valayer E, Patte K, D'Anjou MC, Boulay C, Laffont I.
    Eur J Paediatr Neurol; 2014 Nov 15; 18(6):649-57. PubMed ID: 24931915
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: a randomized, double-blind, placebo-controlled study.
    Wu KP, Ke JY, Chen CY, Chen CL, Chou MY, Pei YC.
    J Child Neurol; 2011 Jul 15; 26(7):838-43. PubMed ID: 21551374
    [Abstract] [Full Text] [Related]

  • 13. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A, Dowson C, Khan MS, Dasgupta P.
    BJU Int; 2009 Jun 15; 103(11):1509-15. PubMed ID: 19389019
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin for the treatment of sialorrhea: a meta-analysis.
    Vashishta R, Nguyen SA, White DR, Gillespie MB.
    Otolaryngol Head Neck Surg; 2013 Feb 15; 148(2):191-6. PubMed ID: 23112272
    [Abstract] [Full Text] [Related]

  • 15. [The efficacy of botulinum toxin-A in the treatment of hypersalivation in children with cerebral palsy].
    Alataş N, Yazgan P, Oztürk A, San I.
    Kulak Burun Bogaz Ihtis Derg; 2006 Feb 15; 16(2):49-53. PubMed ID: 16763416
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and duration of botulinum toxin treatment for drooling in 131 children.
    Scheffer AR, Erasmus C, van Hulst K, van Limbeek J, Jongerius PH, van den Hoogen FJ.
    Arch Otolaryngol Head Neck Surg; 2010 Sep 15; 136(9):873-7. PubMed ID: 20855679
    [Abstract] [Full Text] [Related]

  • 17. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
    Petracca M, Guidubaldi A, Ricciardi L, Ialongo T, Del Grande A, Mulas D, Di Stasio E, Bentivoglio AR.
    Toxicon; 2015 Dec 01; 107(Pt A):129-40. PubMed ID: 26327120
    [Abstract] [Full Text] [Related]

  • 18. Botulinum toxin injections for chronic sialorrhoea in children are effective regardless of the degree of neurological dysfunction: A single tertiary institution experience.
    Mahadevan M, Gruber M, Bilish D, Edwards K, Davies-Payne D, van der Meer G.
    Int J Pediatr Otorhinolaryngol; 2016 Sep 01; 88():142-5. PubMed ID: 27497402
    [Abstract] [Full Text] [Related]

  • 19. Management of Frey's syndrome and hypersialorrhea with botulinum toxin.
    Guntinas-Lichius O.
    Facial Plast Surg Clin North Am; 2003 Nov 01; 11(4):503-13. PubMed ID: 15062255
    [Abstract] [Full Text] [Related]

  • 20. Surgical management of drooling: a meta-analysis.
    Reed J, Mans CK, Brietzke SE.
    Arch Otolaryngol Head Neck Surg; 2009 Sep 01; 135(9):924-31. PubMed ID: 19770427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.